You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 33 No. 3, March 1976 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Desmosterol in Human and Experimental Brain Tumors in Tissue Culture

Joseph F. Weiss, PhD; Humberto Cravioto, MD; Karen Bennett; Elvira deC. Weiss, MS; Joseph Ransohoff, MD

Arch Neurol. 1976;33(3):180-182.


Abstract

• Desmosterol, a possible chemical indicator of brain tumors, was detected in cells of neurogenic, nitrosourea-induced rat tumors (neurinomas and gliomas, C6 cell line) and in human astrocytomas grown in lipid-poor media. A further increase in the amount of cell desmosterol was obtained when triparanol was added to media containing delipidized serum. Cholesterol was replaced almost completely by desmosterol in tumor cells grown in media containing nontoxic levels of 20,25-diazacholesterol. Desmosterol did not accumulate when these inhibitors of desmosterol-reductase were added to culture media containing cholesterol and other lipids (whole fetal calf serum). The results demonstrate that tumors of the nervous system grown in tissue culture are capable of sterol synthesis, and indicate that a central mechanism of cholesterol synthesis is operative in these cells, which may be related to the availability of exogenous cholesterol. It is concluded that these findings are relevant to clinical studies on the use of cholesterol inhibitors as tools for the detection of brain tumor activity.



Author Affiliations

From the Laboratory of Neuropathology, and the departments of pathology and neurosurgery, New York University Medical Center, New York. Dr Weiss is now with the Radiation Biology Department, Armed Forces Radiobiology Research Institute, Bethesda, Md.


Footnotes

Accepted for publication Feb 18, 1975.

Reprint requests to Laboratory of Neuropathology, Department of Pathology, New York University Medical Center, 550 First Ave, New York, NY 10016 (Dr Cravioto).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cholesterol Substitution Increases the Structural Heterogeneity of Caveolae
Jansen et al.
J. Biol. Chem. 2008;283:14610-14618.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1976 American Medical Association. All Rights Reserved.